neratinib: Clinical Trials

4 trials of neratinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Recruiting 2

Follow neratinib: new trials by email Literature Review of neratinib trials Research Report on neratinib

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalized Medicine for Advanced Biliary Cancer Patients
Futibatinib, Ivosidenib, Zanidatamab - Biliary Tract Neoplasms
Phase 3RecruitingUNICANCER8002024-07-182026-05-19
Adjuvant Trastuzumab Plus Neratinib in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Neoadjuvant Trastuzumab Plus Pertuzumab
Trastuzumab and neratinib, Trastuzumab and Pertuzumab - Early-stage Breast Cancer, HER2-positive Breast Cancer
Phase 3RecruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University3002023-03-142025-09-25
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting
neratinib, capecitabine, lapatinib - HER2+ Metastatic Breast Cancer (MBC)
Phase 3CompletedPuma Biotechnology, Inc.6212013-03-292021-06-11
Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer
neratinib, placebo - Breast Cancer
Phase 3CompletedPuma Biotechnology, Inc.28402009-07-092021-06-11

Conditions studied

Breast Neoplasms (2)  ·  Biliary Tract Neoplasms (1)

Sponsors

Puma Biotechnology, Inc. (2)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)  ·  UNICANCER (1)

Countries

Belgium (3)  ·  France (3)  ·  United Kingdom (3)  ·  Australia (2)  ·  Brazil (2)  ·  Canada (2)  ·  China (2)  ·  Czechia (2)  ·  Denmark (2)  ·  Germany (2)  ·  Hong Kong (2)  ·  Israel (2)  ·  Italy (2)  ·  Japan (2)  ·  Netherlands (2)

Top investigators

Ivan Borbath, MD (1)  ·  John Bridgewater, MD (1)  ·  Juan W Valle (1)  ·  Julien Edeline, MD (1)  ·  Malka David, MD (1)

Results publications

PMID 26874901, PMID 29146401, PMID 30689703, PMID 30813966, PMID 30867034, PMID 31140297, PMID 32678716, PMID 34553296, PMID 36898233